Table 2. Treatment of metastatic disease.

Treatment modality	Percentage (N = 131)	N
Surgery	2.3%	3
Chemotherapy Taxane Non-taxane	63.4%	83 37 46
Radiotherapy	42.7%	56
Hormonal therapy	57.3%	75
Trastuzumab	6.1%	8